Home
About
Core Values
Leadership Team
Products
Pharmaceuticals
Active Pharmaceutical Ingredients (APIs)
Pellets
Pharma Intermediates & CRAMS
Impurities
Excipients, Catalysts and High Grade Solvents
Finished Formulation
Food & Nutraceuticals
Phytochemicals and Extracts
Essential Oils
Probiotics
Amino Acids
Protein Hydrolysates
Other food and feed ingredients
Cosmetics
Cosmetics Ingredients
Cosmetics Colours
Specialty & Fine Chemicals
Specialty and Fine Chemicals (Product Range)
Dyes
Acid Dyes
Direct Dyes
Reactive Dyes
Pigments & Driers
Organic Pigments
Inorganic Pigments
Paint Driers
Molkem Labs
Drug Development Services
Pharmaceutical Formulation Company
Analytical Research & Development
Regulatory Services
Analytical & Microbiological Services
Formulation Development
Career
Life at Molkem
Contact
Blog
Global - English
Brazil - Portuguese
Thailand - Thai
Middle East - Arabic
Vietnam - Vietnamese
Spain - Spanish
Colombia - Spanish
Argentina - Spanish
Global - English
Brazil - Portuguese
Thailand - Thai
Middle East - Arabic
Vietnam - Vietnamese
Spain - Spanish
Colombia - Spanish
Argentina - Spanish
Contact Info
401, Naindhara, Near GNFC Info Tower S.G. Highway,
Bodakdev, Ahmedabad - 380054, Gujarat, India
hello@molkem.com
+91 7961202500
Dimethyl Fumarate Pellets
Molkem
Pharmaceuticals
Pellets
Dimethyl Fumarate Pellets
CAS
– 624-49-7
GMP
– Yes
Strength
– 30% , 55%
Segment
– Treatment of Multiple Sclerosis
DMF
– USDMF
Add to Enquiry
Related Product
Voriconazole Micro pellets
Vitamin D3 pellets
Vitamin B Complex and Vitamin C Pellets
Venlafaxine Hydrochloride Pellets
Country
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo (Brazzaville)
Congo (Kinshasa)
Costa Rica
Croatia
Cuba
Cyprus
Czechia
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
North Macedonia
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Can't read the image?
click here
to refresh
Submit Now
Loading
..
Search
Global - English
Brazil - Portuguese
Thailand - Thai
Middle East - Arabic
Vietnam - Vietnamese
Spain - Spanish
Colombia - Spanish
Argentina - Spanish